AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33759038 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (HCT) in advanced SSc
Number of subjects: 0
Study 33759038 — intervention group
Group type: COMPARATOR
Intervention: Hematopoietic stem cell transplantation (HCT) in lupus
Number of subjects: 0
Study 34255238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervitec F (chlorhexidine-fluoride varnish)
Number of subjects: 23
Study 34255238 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 23
Study 34255238 — intervention group
Group type: COMPARATOR
Intervention: Duraphate varnish
Number of subjects: 23
Study 33549193 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 320 mg every 4 weeks
Number of subjects: 567
Study 33549193 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab 45 mg or 90 mg every 12 weeks
Number of subjects: 567
Study 33549193 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 4 weeks
Number of subjects: 567
Study 32535407 — intervention group
Group type: EXPERIMENTAL
Intervention: Social exclusion condition (experimental manipulation)
Number of subjects: 117
Study 32535407 — intervention group
Group type: COMPARATOR
Intervention: Social inclusion condition (control)
Number of subjects: 117
Study 32535407 — intervention group
Group type: EXPERIMENTAL
Intervention: Feelings of rejection (post hoc mediation model)
Number of subjects: 117
Study 35796152 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient management (discharged within 24 hours)
Number of subjects: 776
Study 35796152 — intervention group
Group type: COMPARATOR
Intervention: Inpatient management (discharged after 24 hours)
Number of subjects: 776
Study 35796152 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient management
Number of subjects: 776
Study 35796152 — intervention group
Group type: COMPARATOR
Intervention: Inpatient management
Number of subjects: 776
Study 33636381 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 29
Study 33636381 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 29
Study 33636381 — intervention group
Group type: COMPARATOR
Intervention: Both groups (ESWT and Surgery)
Number of subjects: 29
Study 32252789 — intervention group
Group type: EXPERIMENTAL
Intervention: PRENACEL program (SMS intervention)
Number of subjects: 186
Study 32252789 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care (Control)
Number of subjects: 186
Study 32252789 — intervention group
Group type: COMPARATOR
Intervention: Intervention group (not opting for PRENACEL)
Number of subjects: 186
Study 33295965 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Registries of Acute Coronary Events (GRACE) risk score (GRS) implementation
Number of subjects: 2318
Study 33295965 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Registries of Acute Coronies Events (GRACE) risk score (GRS) implementation
Number of subjects: 2318
Study 32126972 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical function tests (Six-Minute-Walk-Test, Sit-to-Stand-Test, grip strength, knee extension strength)
Number of subjects: 100
Study 32126972 — intervention group
Group type: COMPARATOR
Intervention: Comparison to normative data
Number of subjects: 100
Study 32126972 — intervention group
Group type: COMPARATOR
Intervention: Comparison to other cancer populations
Number of subjects: 100
Study 34157675 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise snacking
Number of subjects: 63
Study 34157675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi snacking
Number of subjects: 63
Study 34157675 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of exercise snacking and tai chi snacking
Number of subjects: 63
Study 34157675 — intervention group
Group type: COMPARATOR
Intervention: Control (UK National Health Service Web pages)
Number of subjects: 63
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD diagnosis
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression diagnosis
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Head trauma
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical violence exposure
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide risk
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory loss
Number of subjects: 200
Study 33755695 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of PTSD and depression with memory loss
Number of subjects: 200
Study 32700217 — intervention group
Group type: EXPERIMENTAL
Intervention: TIME program (Telehealth-supported, Integrated care with CHWs, and MEdication-access)
Number of subjects: 89
Study 32700217 — intervention group
Group type: COMPARATOR
Intervention: Usual care (wait-list control)
Number of subjects: 89
Study 34187117 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG (2 tablets, 300 mg)
Number of subjects: 50
Study 34187117 — intervention group
Group type: COMPARATOR
Intervention: Wheat flour (placebo)
Number of subjects: 50
Study 36412344 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF (Coronally Advanced Flap)
Number of subjects: 15
Study 36412344 — intervention group
Group type: COMPARATOR
Intervention: CAF + Resorbable GTR membrane
Number of subjects: 15
Study 33798978 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted 1-SD increase in subjective wellbeing
Number of subjects: 455258
Study 33798978 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted greater neuroticism
Number of subjects: 455258
Study 33798978 — intervention group
Group type: COMPARATOR
Intervention: Personality traits (agreeableness)
Number of subjects: 455258
Study 33798978 — intervention group
Group type: COMPARATOR
Intervention: Personality traits (conscientiousness)
Number of subjects: 455258
Study 33798978 — intervention group
Group type: COMPARATOR
Intervention: Personality traits (openness)
Number of subjects: 455258
Study 33798978 — intervention group
Group type: COMPARATOR
Intervention: Personality traits (neuroticism)
Number of subjects: 455258
Study 33798978 — intervention group
Group type: COMPARATOR
Intervention: Personality traits (extraversion)
Number of subjects: 455258
Study 34927342 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision combined with cross-linked hyaluronic acid (HA)
Number of subjects: 40
Study 34927342 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcision combined with poly-l-lactic acid (PLLA) threads
Number of subjects: 40
Study 34927342 — intervention group
Group type: COMPARATOR
Intervention: Subcision alone
Number of subjects: 40
Study 32331060 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM5 (5mg)
Number of subjects: 949
Study 32331060 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM10 (10mg)
Number of subjects: 949
Study 32331060 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 949
Study 35579171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 253
Study 35579171 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Jiangnan diet high in plants (TJD)
Number of subjects: 253
Study 35579171 — intervention group
Group type: COMPARATOR
Intervention: Control diet low in plants (CD)
Number of subjects: 253
Study 34016536 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable Activity Technology and Action Planning (WATAAP) intervention
Number of subjects: 68
Study 34016536 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 35514231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.001% Edelweiss extract (EWDE)
Number of subjects: 3
Study 35514231 — intervention group
Group type: EXPERIMENTAL
Intervention: Edelweiss extract formulation
Number of subjects: 3
Study 33356027 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater occipital nerve (GON) block
Number of subjects: 82
Study 33356027 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater occipital nerve + supraorbital nerve (GON + SON) block
Number of subjects: 82
Study 32821805 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident-authored ECG email curriculum (10 multiple-choice ECG cases emailed biweekly over 6 months)
Number of subjects: 129
Study 32821805 — intervention group
Group type: COMPARATOR
Intervention: Standard training (control group)
Number of subjects: 129
Study 35232647 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 152
Study 35232647 — intervention group
Group type: COMPARATOR
Intervention: UDCA
Number of subjects: 152
Study 35232647 — intervention group
Group type: COMPARATOR
Intervention: Digestive enzyme
Number of subjects: 152
Study 33375442 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional eating
Number of subjects: 24968
Study 33375442 — intervention group
Group type: EXPERIMENTAL
Intervention: Worries related to personal economy
Number of subjects: 24968
Study 33375442 — intervention group
Group type: EXPERIMENTAL
Intervention: Worries related to health
Number of subjects: 24968
Study 33375442 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 24968
Study 33375442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of high-sugar foods and beverages
Number of subjects: 24968
Study 33478428 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly rifapentine and isoniazid regimen (self-administered for 12 weeks)
Number of subjects: 52
Study 33478428 — intervention group
Group type: COMPARATOR
Intervention: Daily rifampicin and isoniazid regimen (self-administered for 12 weeks)
Number of subjects: 52
Study 33478428 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (weekly rifapentine/isoniazid and daily rifampicin/isoniazid)
Number of subjects: 52
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Employed mothers with short duration of maternity leave
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Full time employees
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Employees in private organizations
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers without flexible work time
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers not pumping breast milk
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers without a lactation break
Number of subjects: 313
Study 32019563 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers with workplace far from their child
Number of subjects: 313
Study 34697780 — intervention group
Group type: EXPERIMENTAL
Intervention: ApBM+ (n=26)
Number of subjects: 67
Study 34697780 — intervention group
Group type: COMPARATOR
Intervention: Standard-ApBM (n=19)
Number of subjects: 67
Study 34697780 — intervention group
Group type: COMPARATOR
Intervention: Sham-ApBM (n=22)
Number of subjects: 67
Study 33969866 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered CBT-based intervention
Number of subjects: 177
Study 33969866 — intervention group
Group type: COMPARATOR
Intervention: Attention control (general health advice)
Number of subjects: 177
Study 35580239 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study 35580239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33041092 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (multimodal at home and in-hospital for approximately four weeks)
Number of subjects: 47
Study 33552685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (P)
Number of subjects: 256
Study 33552685 — intervention group
Group type: COMPARATOR
Intervention: Combination of pembrolizumab with platinum-based chemotherapy (PCT)
Number of subjects: 256
Study 33093237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to TCE after age 50 years
Number of subjects: 38375
Study 33093237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to TCE with over 20 years of latency
Number of subjects: 38375
Study 33093237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to TCE associated with ER+ tumours after age 50 years
Number of subjects: 38375
Study 35899371 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal music program
Number of subjects: 84
Study 35899371 — intervention group
Group type: COMPARATOR
Intervention: Active control Lego program
Number of subjects: 84
Study 35899371 — intervention group
Group type: COMPARATOR
Intervention: No treatment control condition
Number of subjects: 84
Study 34102783 — intervention group
Group type: COMPARATOR
Intervention: Oral glucocorticoid (prednisone) one week before and three weeks after operation
Number of subjects: 122
Study 35328996 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care Model (ICM) intervention
Number of subjects: 143
Study 35328996 — intervention group
Group type: COMPARATOR
Intervention: Usual geriatric care (Control)
Number of subjects: 143
Study 32277364 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of bentysrepinine (50-900 mg)
Number of subjects: 94
Study 32277364 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of bentysrepinine (300 mg and 600 mg)
Number of subjects: 94
Study 32277364 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of bentysrepinine (600 mg) in food-effect study
Number of subjects: 94
Study 32277364 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 94
Study 34663696 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no tenofovir disoproxil and emtricitabin (TDF/FTC))
Number of subjects: 203
Study 34868486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog-training programme (n = 30)
Number of subjects: 53
Study 34868486 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 23)
Number of subjects: 53
Study 34868486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dogs' behaviour (measured in both groups)
Number of subjects: 53
Study 36038416 — intervention group
Group type: EXPERIMENTAL
Intervention: Brigatinib
Number of subjects: 275
Study 36038416 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 275
Study 33872308 — intervention group
Group type: EXPERIMENTAL
Intervention: MRLocus method for Bayesian estimation of gene-to-trait effect from eQTL and GWAS summary data
Number of subjects: 0
Study 33872308 — intervention group
Group type: EXPERIMENTAL
Intervention: MRLocus method applied to five candidate causal genes
Number of subjects: 0
Study 33691268 — intervention group
Group type: EXPERIMENTAL
Intervention: Bra prescription (wearing a prescribed bra every day for eight weeks)
Number of subjects: 18
Study 33691268 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 18
Study 32174470 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz high-frequency rTMS
Number of subjects: 385
Study 32174470 — intervention group
Group type: COMPARATOR
Intervention: intermittent theta-burst stimulation (iTBS)
Number of subjects: 385
Study 35148517 — intervention group
Group type: EXPERIMENTAL
Intervention: C1-ring osteosynthesis
Number of subjects: 73
Study 35148517 — intervention group
Group type: COMPARATOR
Intervention: C1-2 fixation fusion
Number of subjects: 73
Study 34659237 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac vaccine
Number of subjects: 2263
Study 32383125 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine for PEP
Number of subjects: 1500
Study 32383125 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine for PET
Number of subjects: 1500
Study 35666937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 126
Study 35666937 — intervention group
Group type: COMPARATOR
Intervention: Written Exposure Therapy (WET)
Number of subjects: 126
Study 34433377 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left DLPFC
Number of subjects: 15
Study 34433377 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over left DLPFC
Number of subjects: 15
Study 34433377 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 34196397 — intervention group
Group type: EXPERIMENTAL
Intervention: SNOT-22
Number of subjects: 113
Study 32679218 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiac disease (CD) patients
Number of subjects: 48119
Study 32679218 — intervention group
Group type: COMPARATOR
Intervention: Reference individuals
Number of subjects: 48119
Study 35080060 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop brain state-dependent stimulation in the form of auditory tones (STIM)
Number of subjects: 24
Study 35080060 — intervention group
Group type: COMPARATOR
Intervention: No tones (SHAM)
Number of subjects: 24
Study 33710261 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g Schisandra chinensis Baillon extract (SCe) daily for 12 weeks
Number of subjects: 54
Study 33710261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 32415923 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol combined with sevelamer carbonate
Number of subjects: 180
Study 32415923 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol alone
Number of subjects: 180
Study 36307427 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide 250 mg/day
Number of subjects: 86
Study 36307427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 34286837 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity-based lifestyle intervention (PAL-I) for 3 months
Number of subjects: 15
Study 32092321 — intervention group
Group type: EXPERIMENTAL
Intervention: iNO 30 μg/kg ideal body weight/h
Number of subjects: 41
Study 32092321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 32092321 — intervention group
Group type: EXPERIMENTAL
Intervention: iNO 30, 45, and 75
Number of subjects: 41
Study 33065955 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (single-dose studies)
Number of subjects: 1377
Study 33065955 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (repeat-dose studies)
Number of subjects: 1377
Study 33065955 — intervention group
Group type: COMPARATOR
Intervention: Placebo (single-dose studies)
Number of subjects: 1377
Study 35045900 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief video-based intervention at day 1 and booster video at day 14
Number of subjects: 350
Study 35045900 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief video-based intervention at day 1 only
Number of subjects: 350
Study 35045900 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control
Number of subjects: 350
Study 32673228 — intervention group
Group type: EXPERIMENTAL
Intervention: GRASP framework
Number of subjects: 194
Study 32673228 — intervention group
Group type: COMPARATOR
Intervention: Control group (derivation publications)
Number of subjects: 194
Study 36208242 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with antivirals (including recombinant interferon alpha-2b and CHOP therapy, zidovudine combined with CHOP therapy, CHOP regimen combined with interferon and zidovudine)
Number of subjects: 49
Study 36208242 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (CHOP therapy)
Number of subjects: 49
Study 34684407 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of hydrolyzed pine nut oil (PNO-FFA)
Number of subjects: 9
Study 34684407 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 3 g hydrolyzed pine nut oil and 3 g olive oil (PNO-OO)
Number of subjects: 9
Study 34684407 — intervention group
Group type: EXPERIMENTAL
Intervention: Both oil treatments (PNO-FFA and PNO-OO)
Number of subjects: 9
Study 34684407 — intervention group
Group type: COMPARATOR
Intervention: No oil
Number of subjects: 9
Study 32630079 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipigo®
Number of subjects: 120
Study 32630079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33129990 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Study using Eureka platform
Number of subjects: 930
Study 33129990 — intervention group
Group type: EXPERIMENTAL
Intervention: Geofencing for hospitalization tracking
Number of subjects: 930
Study 33129990 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly digital hospitalization surveys
Number of subjects: 930
Study 32151115 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 80
Study 32151115 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine with atropine
Number of subjects: 80
Study 36223366 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy availability (LEA) trial (19.9 ± 0.2 kcal/kg fat free mass [FFM]/day)
Number of subjects: 10
Study 36223366 — intervention group
Group type: COMPARATOR
Intervention: Normal energy availability (NEA) trial (46.4 ± 0.1 kcal/kg FFM/day)
Number of subjects: 10
Study 36223366 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy availability (LEA) trial
Number of subjects: 10
Study 34020123 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait perturbation protocol (treadmill-based, 10-week therapy)
Number of subjects: 24
Study 36396308 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid intervention
Number of subjects: 0
Study 36396308 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32467037 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian vein group
Number of subjects: 415
Study 32467037 — intervention group
Group type: COMPARATOR
Intervention: Internal jugular vein group
Number of subjects: 415
Study 32787934 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefilled pen
Number of subjects: 23
Study 35932584 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal subtyping analysis
Number of subjects: 95
Study 35932584 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor variables and gray matter volume in the right medial postcentral gyrus
Number of subjects: 95
Study 33444689 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS) via tragus
Number of subjects: 0
Study 33444689 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS) via cymba conchae
Number of subjects: 0
Study 33444689 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation via earlobe
Number of subjects: 0